This strategic acquisition combines healthcare intelligence with advanced actuarial expertise to improve healthcare outcomes and lay a foundation for Actuarial Copilots
Innovaccer, a leading healthcare AI company, announced its acquisition of Humbi AI (Actuarial Intelligence), a specialized healthcare actuarial software, services and analytics company. This marks Innovaccer’s third acquisition, following Cured and Pharmacy Quality Solutions (PQS) in 2024, solidifying the company’s commitment to drive advanced healthcare transformation.
Humbi AI’s Actuarial Intelligence will be an integral component of Innovaccer’s Healthcare Intelligence Cloud, unlocking new opportunities for providers, payers, and life sciences organizations. The acquisition combines Humbi AI’s expertise in Medicare and Medicaid data, spanning over 200 million lives, with Innovaccer’s Intelligence Cloud. This integration will enhance Innovaccer’s ability to help healthcare organizations improve health outcomes and manage risk and performance more effectively. It also sets the stage for Innovaccer’s Actuarial Copilots, which will help actuaries complete work faster and more efficiently.
“This acquisition is a pivotal moment in Innovaccer’s ongoing mission to transform healthcare by accelerating its shift to value-based care,” said Abhinav Shashank, co-founder and CEO of Innovaccer. “Humbi AI’s actuarial expertise complements our existing platform, giving us the unique ability to help healthcare organizations design smarter value-based contracts, optimize drug commercialization, and manage performance in unprecedented ways.”
Also Read: Mayo Clinic Advances Personalized Medicine with Microsoft & Cerebras
Humbi AI’s solutions will allow Innovaccer to address critical challenges across the healthcare ecosystem by touching all points of care. For providers and Accountable Care Organizations (ACOs), it will enable more intelligent, data-driven value-based contracts and financial performance. For payers, Humbi AI’s actuarial expertise and analytics will improve contract performance, payer benchmarking, and optimize provider network management. In the life sciences sector, Humbi AI’s Actuarial Intelligence will help companies optimize drug commercialization through data-driven insights, clinical effectiveness analysis and utilization metrics.
“At Humbi AI, we believe Actuarial Intelligence is the key to turning complex healthcare data into strategic action,” said Puneet Budhiraja, founder and CEO at Humbi AI. “By joining Innovaccer, we are amplifying our ability to help organizations navigate their most critical decisions with actuarial expertise and advanced analytics.”
Innovaccer recently announced its Series F fundraise, refining its approach to leverage the power of AI technologies. This strategic move reinforces Innovaccer’s vision to provide customers with a more holistic and effective combination of AI and actuarial solutions.
Humbi AI’s leadership team will continue to drive the company’s strategic initiative, ensuring continuity for their customers. Upon integration, Humbi AI’s customers will have access to Innovaccer‘s Data activation platform, EHR connect and clinical team to guide them through the end-to-end VBC platform.
Source: Businesswire
